You are here

  • Home
  • Archive
  • Volume 27, Issue 5
  • Combined Gene Therapy Using AdsVEGFR2 and AdsTie2 With Chemotherapy Reduces the Growth of Human Ovarian Cancer and Formation of Ascites in Mice

Article info

Article menu
Download PDFPDF
Basic Science
Combined Gene Therapy Using AdsVEGFR2 and AdsTie2 With Chemotherapy Reduces the Growth of Human Ovarian Cancer and Formation of Ascites in Mice

Authors

  • Laura Tuppurainen Department of Biotechnology and Molecular Medicine, A. I. Virtanen Institute for Molecular Sciences, and PubMed articlesGoogle scholar articles
  • Hanna Sallinen Department of Biotechnology and Molecular Medicine, A. I. Virtanen Institute for Molecular Sciences, andInstitute of Clinical Medicine, Gynecology, and Pathology and Forensic Medicine, University of Eastern Finland;Department of Gynecology, Kuopio University Hospital; PubMed articlesGoogle scholar articles
  • Anni Karvonen Department of Biotechnology and Molecular Medicine, A. I. Virtanen Institute for Molecular Sciences, and PubMed articlesGoogle scholar articles
  • Elina Valkonen Department of Biotechnology and Molecular Medicine, A. I. Virtanen Institute for Molecular Sciences, and PubMed articlesGoogle scholar articles
  • Hanne Laakso Department of Biotechnology and Molecular Medicine, A. I. Virtanen Institute for Molecular Sciences, andNMR Research Group, A. I. Virtanen Institute for Molecular Sciences, University of Eastern Finland; PubMed articlesGoogle scholar articles
  • Timo Liimatainen Department of Biotechnology and Molecular Medicine, A. I. Virtanen Institute for Molecular Sciences, andNMR Research Group, A. I. Virtanen Institute for Molecular Sciences, University of Eastern Finland; PubMed articlesGoogle scholar articles
  • Elisa Hytönen Department of Biotechnology and Molecular Medicine, A. I. Virtanen Institute for Molecular Sciences, and PubMed articlesGoogle scholar articles
  • Kirsi Hämäläinen Institute of Clinical Medicine, Gynecology, and Pathology and Forensic Medicine, University of Eastern Finland;Department of Pathology and PubMed articlesGoogle scholar articles
  • Veli-Matti Kosma Institute of Clinical Medicine, Gynecology, and Pathology and Forensic Medicine, University of Eastern Finland;Department of Pathology and PubMed articlesGoogle scholar articles
  • Maarit Anttila Department of Biotechnology and Molecular Medicine, A. I. Virtanen Institute for Molecular Sciences, andInstitute of Clinical Medicine, Gynecology, and Pathology and Forensic Medicine, University of Eastern Finland;Department of Gynecology, Kuopio University Hospital; PubMed articlesGoogle scholar articles
  • Seppo Ylä-Herttuala Department of Biotechnology and Molecular Medicine, A. I. Virtanen Institute for Molecular Sciences, andGene Therapy Unit, Kuopio University Hospital; andScience Service Center, Kuopio University Hospital, Kuopio, Finland. PubMed articlesGoogle scholar articles
  1. Address correspondence and reprint requests to Seppo Ylä-Herttuala, MD, PhD, FESC, A. I. Virtanen Institute, University of Eastern Finland, PO Box 1627, Kuopio FIN-70211, Finland. E-mail: Seppo.Ylaherttuala@uef.fi.

Citation

Tuppurainen L, Sallinen H, Karvonen A, et al
Combined Gene Therapy Using AdsVEGFR2 and AdsTie2 With Chemotherapy Reduces the Growth of Human Ovarian Cancer and Formation of Ascites in Mice
International Journal of Gynecologic Cancer 2017;27:879-886.

Publication history

  • Received December 15, 2016
  • First published June 1, 2017.
Online issue publication 
February 26, 2019

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

Copyright © 2017 by IGCS and ESGO